Plaintiffs attorney Thomas Girardi has been ordered to turn over documents detailing his personal net worth and the finances of his Los Angeles law firm, Girardi Keese, as part of a lawsuit alleging he misappropriated more than $12.5 million from a settlement over hormone replacement therapy drug Prempro.
The plaintiffs are 28 of 138 Girardi clients who settled claims in 2011 that they got breast cancer after taking Prempro. In their 2014 lawsuit, the women allege Girardi never disclosed to them the terms of the $17 million settlement or provided accounting records, in violation of California laws.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
